The firm said that the system's automation and flexibility will help centers be more productive within a testing specialty that can require extensive hands-on time.
Seventh Sense Biosystems markets a one-step, push-button device called Tap that uses a microneedle array to collect capillary blood from the arm.
The fluid in the skin can be used to detect systemic biomarkers but has previously been too inaccessible. A new paper-based method could change that.
The Swiss company's new immunohematology microarray runs on the company's MosaiQ high-throughput automated platform for blood transfusion testing.
The NEO Iris instrument uses the company's Capture solid phase technology for antibody screening and identification, and can run up to 60 tests and screens per hour.
The Canadian company said it will use the funding to support the US launch of its rapid, noninvasive test for platelet activation status.
Designed for small and medium-sized labs, the system offers automated blood typing and screening based on gel card technology with minimum user intervention.
CEO Yoel Ezra said the firm plans to deploy a prototype in pilot studies next year, and is eyeing opportunities in the US, Europe, India, and the Middle East.
Magnolia has amended a complaint filed in a US District Court to allege that Kurin infringes four Magnolia patents.